Gilead Sciences, Inc. (ETR:GIS)
105.38
-1.82 (-1.70%)
At close: Dec 22, 2025
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
€1,408,571
Profits / Employee
€392,736
Market Cap
131.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17,600 | -400 | -2.22% |
| Dec 31, 2023 | 18,000 | 1,000 | 5.88% |
| Dec 31, 2022 | 17,000 | 2,600 | 18.06% |
| Dec 31, 2021 | 14,400 | 800 | 5.88% |
| Dec 31, 2020 | 13,600 | 1,800 | 15.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
Gilead Sciences News
- 3 days ago - Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal - Benzinga
- 3 days ago - Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay - WSJ
- 3 days ago - Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts - Benzinga
- 3 days ago - Trump strikes deal with US drugmakers to cut Medicaid medicine costs - The Guardian
- 3 days ago - Gilead (GILD) Strikes Deal to Cut Drug Costs With U.S. Government - GuruFocus
- 3 days ago - Nine of the largest pharma companies ink deals with Trump to lower drug prices - CNBC
- 3 days ago - Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans - Business Wire
- 3 days ago - GILD's Lenacapavir Gains UK Approval for HIV-1 Prevention - GuruFocus